Open AccessBrazil advances in its research on Covid-19 in patients with autoimmune diseases
Author(s) -
Estafania Fajardo
Publication year - 2021
Publication title -
global rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2709-5533
DOI - 10.46856/grp.233.et091
Subject(s) - covid-19 , pandemic , disease , medicine , vaccination , family medicine , immunology , virology , infectious disease (medical specialty) , pathology , outbreak
Dr. Cláudia Marques addresses some doubts regarding the development of the virus in patients with rheumatic diseases and talks about the studies being carried out in Brazil. In a dialogue with Dr. Cláudia Marques, rheumatologist and professor at the Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil, different questions and research on Covid-19 and autoimmune diseases are addressed, taking as a starting point that despite the large amount of information produced in the last year on SARS-CoV-2, there are still some doubts, mainly related to the frequency of Covid-19 in patients with rheumatic diseases. At the beginning of the pandemic the great fear was that these patients would develop more severe forms of the disease and that, to date, is not very well established, taking into account that studies have different results in this regard. In this new video blog we address the different concerns about the virus, its vaccination and the tests that are currently being developed in Brazil to provide an answer. "